34 filings
8-K
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
8-K
STSA
Satsuma Pharmaceuticals Inc
18 May 23
January 2024 PDUFA date expected
4:20pm
8-K
STSA
Satsuma Pharmaceuticals Inc
3 May 23
Other Events
4:11pm
8-K
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
STSA
Satsuma Pharmaceuticals Inc
28 Mar 23
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022
4:52pm
8-K
82e e16jmtlj7fs
16 Feb 23
Other Events
4:00pm
8-K
ld4uef2
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
8-K
ek38ot1529lgqy
30 Nov 22
Other Events
4:00pm
8-K
wa7hkf5
14 Nov 22
Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase
4:04pm
8-K
eovaw8mow
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
8-K
709qrg0w
3 Nov 22
Satsuma Pharmaceuticals Reports Third Quarter 2022 Financial Results and Recent Business Highlights
4:00pm
8-K
atas32x
28 Oct 22
Termination of a Material Definitive Agreement
4:01pm
8-K
oechsqya1
20 Sep 22
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
5:03pm
8-K
se4t z6drm
9 Aug 22
Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results
12:00am
8-K
96jwd8vo
7 Jun 22
Submission of Matters to a Vote of Security Holders
6:31am
8-K
5snc2s0n70 u7gkggr
10 May 22
Satsuma Pharmaceuticals Reports First Quarter 2022 Financial Results
4:02pm
8-K
213c6fc34vi tctxvjf
15 Mar 22
Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth Quarter Financial Results and Business Highlights
4:40pm
8-K
73zbeeb
9 Nov 21
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results
5:00pm
8-K
go0gyrj6ath5
12 Oct 21
Departure of Directors or Certain Officers
5:01pm
8-K
zi90c4uinqe7 ix
10 Aug 21
Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:01pm